JOSÉ JOAQUÍN
PORTU ZAPIRAIN
Hospital Universitario Virgen del Rocío
Sevilla, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Virgen del Rocío (9)
2023
-
Post-mortem findings in Spanish patients with COVID-19; a special focus on superinfections
Frontiers in Medicine, Vol. 10
2021
-
Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study
The Lancet Infectious Diseases, Vol. 21, Núm. 6, pp. 783-792
-
Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)
Clinical Microbiology and Infection, Vol. 27, Núm. 2, pp. 244-252
2020
-
Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain
Clinical Microbiology and Infection, Vol. 26, Núm. 11, pp. 1525-1536
2015
-
Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: The International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program
Journal of Viral Hepatitis, Vol. 22, Núm. 5, pp. 469-480
2010
-
Factores asociados con la no realización de la prueba de la tuberculina en una cohorte de pacientes VIH positivos
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 28, Núm. 4, pp. 215-221
2009
-
Eligibility for and outcome of treatment of latent tuberculosis infection in a cohort of HIV-infected people in Spain
BMC Infectious Diseases, Vol. 10
2008
-
Low rate of adverse hepatic events associated with fosamprenavir/ritonavir-based antiretroviral regimens
HIV Clinical Trials, Vol. 9, Núm. 5, pp. 309-313
2007
-
Prevalence of M. tuberculosis infection and tuberculosis disease among HIV-infected people in Spain
International Journal of Tuberculosis and Lung Disease, Vol. 11, Núm. 11, pp. 1196-1202